Northern Right Capital Management’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.8M Buy
4,890,584
+800,415
+20% +$4.21M 7.65% 4
2026
Q1
$17.1M Buy
4,090,169
+1,221,155
+43% +$5.88M 6.08% 7
2025
Q4
$13.8M Buy
+2,869,014
New +$13.9M 3.62% 14
2024
Q3
Sell
-1,156,600
Closed -$4.02M 28
2024
Q2
$4.02M Sell
1,156,600
-44,268
-4% -$148K 1.48% 22
2024
Q1
$3.42M Buy
1,200,868
+463,447
+63% +$1.43M 1.23% 25
2023
Q4
$2.6M Buy
737,421
+15,089
+2% +$43.3K 1.04% 25
2023
Q3
$1.87M Sell
722,332
-425,100
-37% -$1.49M 0.73% 24
2023
Q2
$4.52M Buy
+1,147,432
New +$3.64M 1.82% 19

Other funds holding SRTA

Northern Right Capital Management's SRTA Position: Q2 2026 in Review

Northern Right Capital Management increased its Strata Critical Medical Inc (SRTA) stake by 20% in Q2 2026, buying an estimated $4.21M and bringing the position to 4,890,584 shares worth $25.8M. The position accounts for 7.65% of the portfolio, ranked #4.

Northern Right Capital Management first reported a position in SRTA in Q2 2023 and has held it in 8 quarters since. 140 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • Northern Right Capital Management held 4,890,584 shares of Strata Critical Medical Inc worth $25.8M as of Q2 2026.
  • Northern Right Capital Management bought 800,415 Strata Critical Medical Inc shares in Q2 2026, an estimated $4.21M.
  • Strata Critical Medical Inc made up 7.65% of Northern Right Capital Management's portfolio in Q2 2026, its #4 holding.
  • Northern Right Capital Management first reported a position in Strata Critical Medical Inc in Q2 2023 and has held it in 8 quarters since.
  • 140 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Northern Right Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.